News & Trends - Pharmaceuticals
New discovery to reduce renal failure in patients with diabetic kidney disease
Researchers from Monash University’s Central Clinical School in Australia have found that a drug that has already been tested on other inflammatory diseases can decrease kidney injury caused by diabetes.
Led by Associate Professor Melinda Coughlan from the Department of Diabetes, the five-year study initially discovered that a key immune system pathway, called the complement pathway – which usually protects the body from infection – was hyperactivated and caused inflammation in people with diabetic kidney disease.
Associate Professor Coughlan’s team then discovered this pathway could be disrupted with a drug developed by Associate Professor Trent Woodruff, from the School of Biomedical Sciences at the University of Queensland.
Through collaborative tests on mice with diabetes and in human kidney cells, they could see that the drug helped to support the normal function of the mitochondria within the kidney – known as the “batteries of the cell” – which don’t work properly in people with diabetes.
Associate Professor Coughlan said their discovery, which is being published in the US journal Diabetes on Friday October 18, could potentially lead to a therapy to delay or prevent renal failure in people with diabetic kidney disease.
“We’re saying this is a new link between the immune system and the mitochondria, which could also help patients with diabetic kidney disease by boosting mitochondrial health – so it could protect the kidney in patients with diabetes,” Associate Professor Coughlan said.
Diabetes is a growing global health burden, with 422 million adults – or one in 11 people – diagnosed with the disease. Each year, some 1.5 million people die from diabetes-related disease.
In Australia, 298 people are diagnosed with diabetes every day, with one in four adults living with diabetes or pre-diabetes. The total annual cost impact of diabetes in Australia is estimated at $14.6 billion.
It’s the leading cause of blindness in working adults, and can cause stroke, heart disease, limb amputations, and is the leading cause of renal failure.
Associate Professor Coughlan said while the discovery wasn’t a cure or prevention for diabetes, it could have enormous health and financial benefits.
“Findings like this will become important for managing the health of people with diabetes. The economic burden of diabetes is huge, and this could potentially help reduce that.”
Associate Professor Coughlan, whose work includes investigating dietary factors leading to the onset of diabetes and its complications, said they would now look at developing medicines that target this pathway for future use in the clinic.
The global problem of diabetes
- Diabetes is a growing global health burden, with 422 million adults – or one in 11 people – diagnosed with the disease. Each year, some 1.5 million people die from diabetes-related diseases.
- In Australia, an average of almost 300 people are diagnosed with diabetes every day, with one in four adults living with diabetes or pre-diabetes. The total annual cost impact of diabetes in Australia is estimated at $14.6 billion.
- It is the leading cause of blindness in working adults, and can cause stroke, heart disease, limb amputations, and is the leading cause of renal failure.
You may also like Health Minister addresses Medicines Australia’s PharmAus19
News & Trends - Pharmaceuticals
Healthcare affordability and accessibility top priority for consumers ahead of Federal Budget
Pharma News: With the Federal Budget set to be delivered in just one week, there is a critical need for […]
MoreNews & Trends - Pharmaceuticals
UCB secures registration of rheumatology drug
Pharma News: UCB Australia has secured Therapeutic Goods Administration (TGA) approval of its therapy for psoriatic arthritis (PsA), non-radiographic axial […]
MoreDigital & Innovation
Targeted funding of digital health technologies key to unlocking $5 billion in savings: New report
Digital & Innovation: Integrating digital technology into healthcare more effectively could alleviate pressures on our healthcare system and lead to […]
MoreNews & Trends - MedTech & Diagnostics
Surgeons welcome ‘significant win’ for patients, amidst clash with health insurers
MedTech & Diagnostics News: The Royal Australasian College of Surgeons (RACS) is heralding a significant triumph for Australian patients following […]
More